1. Home
  2. UPST vs GPCR Comparison

UPST vs GPCR Comparison

Compare UPST & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upstart Holdings Inc.

UPST

Upstart Holdings Inc.

HOLD

Current Price

$26.97

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$49.12

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPST
GPCR
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
UPST
GPCR
Price
$26.97
$49.12
Analyst Decision
Buy
Strong Buy
Analyst Count
16
12
Target Price
$45.84
$103.17
AVG Volume (30 Days)
3.6M
697.0K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
131.25
N/A
EPS
N/A
N/A
Revenue
$1,043,857,000.00
N/A
Revenue This Year
$34.45
N/A
Revenue Next Year
$32.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.99
N/A
52 Week Low
$23.97
$15.80
52 Week High
$85.31
$94.90

Technical Indicators

Market Signals
Indicator
UPST
GPCR
Relative Strength Index (RSI) 32.57 50.72
Support Level $25.18 $43.76
Resistance Level $34.84 $57.15
Average True Range (ATR) 1.62 2.73
MACD -0.65 -0.61
Stochastic Oscillator 1.37 36.26

Price Performance

Historical Comparison
UPST
GPCR

About UPST Upstart Holdings Inc.

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The company support development of different lending product offerings, which are grouped into three operating segments - Personal Lending (unsecured personal loans and small dollar loans), Auto Lending (auto refinance, auto retail loans, and auto secured personal loans), and Other (HELOCs and other).

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: